|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006118,
umls-concept:C0008976,
umls-concept:C0030705,
umls-concept:C0185125,
umls-concept:C0220901,
umls-concept:C0555198,
umls-concept:C0918012,
umls-concept:C1273870,
umls-concept:C1540289,
umls-concept:C2587213,
umls-concept:C2698590
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1998-7-23
|
|
pubmed:abstractText |
The MRC brain tumour prognostic index, which uses clinical variables to place patients in different outcome categories, has not been evaluated on a cohort outside a randomised controlled trial. The aims of this study were to (a) determine in a large cohort of patients, derived solely from one centre and not in a clinical trial, whether the MRC prognostic index stratified patients for outcome; (b) compare actual outcomes with those obtained in the original studies; and (c) examine whether neuropathological diagnosis was an independent prognostic variable.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/9647303-1419289,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9647303-1654987,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9647303-2157825,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9647303-2661738,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9647303-2990664,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9647303-3620320,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9647303-6305479,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9647303-7116716,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9647303-7807189,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9647303-7964979,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9647303-8387988,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9647303-8707564
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0022-3050
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
64
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
747-50
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:9647303-Adult,
pubmed-meshheading:9647303-Age Distribution,
pubmed-meshheading:9647303-Aged,
pubmed-meshheading:9647303-Astrocytoma,
pubmed-meshheading:9647303-Brain Neoplasms,
pubmed-meshheading:9647303-Cohort Studies,
pubmed-meshheading:9647303-Disease Progression,
pubmed-meshheading:9647303-Female,
pubmed-meshheading:9647303-Glioma,
pubmed-meshheading:9647303-Humans,
pubmed-meshheading:9647303-Male,
pubmed-meshheading:9647303-Middle Aged,
pubmed-meshheading:9647303-Prognosis,
pubmed-meshheading:9647303-Prospective Studies,
pubmed-meshheading:9647303-Severity of Illness Index,
pubmed-meshheading:9647303-Sex Distribution,
pubmed-meshheading:9647303-Survival Rate
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Application of the MRC brain tumour prognostic index to patients with malignant glioma not managed in randomised control trial.
|
|
pubmed:affiliation |
Department of Clinical Neurosciences, Western General Hospital, Edinburgh, Scotland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
